Skip to main content

Pharma News

Pharma Courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for Boehringer Ingelheim's novel, 3rd-generation, epidermal growth factor receptor (EGFR) mutation-specific tyrosine kinase inhibitor (TKI), BI 1482694 (HM61713). The BTD is based on results from the phase I/II HM-EMSI-101 clinical trial which were presented at the ESMO Asia 2015 Congress in Singapore.

  • AstraZeneca, a global, science-led biopharmaceutical business, has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending the marketing authorisation of Tagrisso (AZD9291, osimertinib) 80mg once-daily tablets for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC).

  • Besides opening up new vistas for humans, ranging from travel to exotic places to enjoying the products and services of those distant lands, international trade and travel also increases risk of spreading infectious diseases, a study says.

  • India became the world's third country with the prowess to manufacture raw materials for nanomedicines, addressed a growing public health concern by approving a new drug for hepatitis C and made strides in 3D printing in healthcare as 2015 ended on a cliff-hanger with the launch of the world's first anti-dengue vaccine in Mexico giving hope to the South Asian country.

  • South Korean health authorities declared an official end to the Middle East Respiratory Syndrome (MERS) outbreak, more than seven months after the first patient was found on May 20.

  • The White House released a plan to combat "global rise" of multidrug-resistant tuberculosis (MDR-TB).

  • While obese children tend to have more muscles, the excess body fat may compromise other functions in their bodies, such as bone growth, says a study.

  • In a first, researchers have shown that a drug that boosts activity in the brain's "garbage disposal" system can decrease levels of toxic proteins associated with Alzheimer's disease and other neurodegenerative disorders.

    [adsense:336x280:8701650588]

Subscribe to Pharma News